hyperglycemia
These results suggest that in uremic humans propranolol independently reduces the hepatic response to glucagon and the insulin secretory response to hyperglycemia and/or hyperglucagonemia.
These results suggest that in uremic humans propranolol independently reduces the hepatic response to <span class="gene" id="3019152-11-102-110">glucagon</span> and the insulin secretory response to <span class="disease" id="3019152-11-149-162">hyperglycemia</span> and/or hyperglucagonemia.